Potential modulating effects of micronutrients on prostate specific antigen (PSA) response to androgen deprivation therapy in prostate cancer

被引：0
|
作者：
Resh, J
Kannan, S
Wei, JT
Dunn, R
机构：
[1] Univ Michigan, Dept Environm Hlth Sci, Nutr Program, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ctr Med, Dept Urol, Ann Arbor, MI 48109 USA
来源：
FASEB JOURNAL | 2002年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A371 / A371
页数：1
相关论文
共 50 条
  • [31] Serum Prostate-Specific Antigen Levels Reflect the Androgen Milieu in Patients With Localized Prostate Cancer Receiving Androgen Deprivation Therapy: Tumor Malignant Potential and Androgen Milieu
    Takizawa, Itsuhiro
    Nishiyama, Tsutomu
    Hara, Noboru
    Isahaya, Etsuko
    Hoshii, Tatsuhiko
    Takahashi, Kota
    PROSTATE, 2010, 70 (13): : 1395 - 1401
  • [32] Androgen deprivation therapy for prostate cancer - the potential of parenteral estrogen
    Ockrim, Jeremy
    Abel, Paul D.
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2009, 62 (03) : 132 - 140
  • [33] Evaluation of the effects of prostate specific antigen (PSA) on prostate cancer bone metastasis
    Lai, Janice S.
    Corey, Eva
    Brown, Lisha G.
    Gross, Ted S.
    Huber, Philippe
    Vessella, Robert L.
    CANCER RESEARCH, 2006, 66 (08)
  • [34] PSP94 expression after androgen deprivation therapy: A comparative study with prostate specific antigen in benign prostate and prostate cancer
    Imasato, Y
    Xuan, JW
    Sakai, H
    Izawa, JI
    Saito, Y
    Chin, JL
    Moussa, M
    JOURNAL OF UROLOGY, 2000, 164 (05): : 1819 - 1824
  • [35] Prostate-Specific Antigen Screening Trials and Prostate Cancer Deaths: The Androgen Deprivation Connection
    Haines, Ian E.
    Miklos, George L. Gabor
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (20): : 1534 - 1539
  • [36] How early is early: Androgen deprivation for prostate-specific antigen relapse in prostate cancer
    Duchesne, Gillian M.
    Syme, Rodney
    Howell, Deborah
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2964 - 2964
  • [37] 68Ga-Labeled Anti-Prostate-Specific Membrane Antigen Peptide as Marker for Androgen Deprivation Therapy Response in Prostate Cancer
    Schlenkhoff, Carl Diedrich
    Gaertner, Florian
    Essler, Markus
    Hauser, Stefan
    Ahmadzadehfar, Hojjat
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (05) : 423 - 425
  • [38] Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality
    D'Amico, Anthony V.
    McLeod, David G.
    Carroll, Peter R.
    Cullen, Jennifer
    Chen, Ming-Hui
    CANCER, 2007, 109 (07) : 1290 - 1295
  • [39] Androgen deprivation decreases prostate specific antigen in the absence of tumor: implications for interpretation of PSA results
    Wenisch, Judith M.
    Mayr, Florian B.
    Spiel, Alexander O.
    Radicioni, Milko
    Jilma, Bernd
    Jilma-Stohlawetz, Petra
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (03) : 431 - 436
  • [40] The use of prostate-specific antigen (PSA) for the monitoring of radiation therapy in prostate cancer
    Schafer, U
    Micke, O
    Hampel, G
    Brandt, B
    Bovenschulte, A
    Semjonow, A
    Willich, N
    ANTICANCER RESEARCH, 1997, 17 (4B) : 2983 - 2986
12345